CHMP provides conditional reprieve for Fampyra
23 May 2011
Mike Ward
Please Login to read the full article.
23 May 2011
Mike Ward
Please Login to read the full article.
RELATED CONTENT
NEWS
- Acorda R&D looks to MS drug Ampyra for cerebral palsy, post-stroke deficits
- Benlysta and Fampyra fail IQWiG test on data deficiencies; Yervoy gets mixed review
- Biogen seeks to retain lead in MS market with US BG-12 submission
- Biogen Idec dumps Dompe to manage costs in Italian and Swiss MS market
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
